STOCK TITAN

UTI (UTI) Form 144/A: 15,000-share resale notice, awards listed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144/A

Rhea-AI Filing Summary

UTI amended a Form 144 reporting proposed sales of Common Stock on the NYSE. The filing lists 15,000 shares and a dollar figure of $536,100.00 with an effective filing date of 05/11/2026. The amendment also itemizes multiple stock awards by grant date and share counts, including awards dated 02/27/2008 (1,250), 02/22/2012 (3,682), 02/20/2013 (2,577), 04/08/2014 (3,892) and 02/27/2025 (3,599).

Positive

  • None.

Negative

  • None.

Insights

Amended notice for proposed sales; lists awards and aggregate figures.

The amendment identifies a proposed sale notice under Form 144/A, naming 15,000 shares and showing $536,100.00 alongside an 05/11/2026 filing date. It also lists specific stock award grant dates with share counts.

Regulatory effect: this is a reporting step to enable public resale under Rule 144 pathways; the actual timing and execution of sales are governed by Rule 144 conditions and market mechanics as applicable.

Lists compensation-related awards that underlie the resale notice.

The filing ties the shares to stock awards (labeled "Compensation") granting specific share amounts by date. Examples include 1,250 shares (02/27/2008) and 3,599 shares (02/27/2025).

These award entries explain the source of the shares being registered for resale; further details about holder identity or execution method are not provided in the excerpt.

Filed shares 15,000 shares Form 144/A filing listed with NYSE
Dollar figure $536,100.00 Amount shown on the filing excerpt
Filing date 05/11/2026 Amended Form 144/A date
Award 02/27/2008 1,250 shares Stock Award dated 02/27/2008, Compensation
Award 02/22/2012 3,682 shares Stock Award dated 02/22/2012, Compensation
Award 02/20/2013 2,577 shares Stock Award dated 02/20/2013, Compensation
Award 04/08/2014 3,892 shares Stock Award dated 04/08/2014, Compensation
Award 02/27/2025 3,599 shares Stock Award dated 02/27/2025, Compensation
Form 144/A regulatory
"Amended notice of proposed sale under Rule 144"
Stock Award financial
"Entries labeled 'Stock Award' with grant dates and share counts"
Compensation financial
"Award entries end with the word 'Compensation' indicating grant source"

144/A: Filer Information

144/A: Issuer Information

144/A: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

144/A: Remarks and Signature

FAQ

What does UTI's amended Form 144/A report?

It reports a proposed sale notice listing 15,000 shares and $536,100.00 with a filing date of 05/11/2026. The filing also itemizes multiple stock awards and their grant dates with share counts.

Which securities are covered in the Form 144/A for UTI?

The filing covers Common Stock, $0.0001 par value listed on the NYSE. The excerpt lists several award grants tied to Common Stock with their respective dates and share counts.

What award grants are listed as sources of the shares?

Listed award grants include 02/27/2008: 1,250 shares, 02/22/2012: 3,682 shares, 02/20/2013: 2,577 shares, 04/08/2014: 3,892 shares, and 02/27/2025: 3,599 shares identified as "Compensation."

Does the filing state how the sales will be executed?

The excerpt lists the securities and award sources but does not provide execution mechanics. It focuses on the proposed resale notice and the underlying stock awards without describing sale methods or timing.

What is the filing date shown on the Form 144/A?

The filing date displayed in the excerpt is 05/11/2026, associated with the amended Form 144/A and the listed common stock figures.